2019年10月7日 · Rheumatic heart disease (RHD) is the only preventable cardiovascular disease which causes significant morbidity and mortality particularly in low- and middle-income countries. Early clinical diagnosis is key, the updated Jones criteria increases the ...

2021年7月28日 · Among delayed RHD presentations, rheumatic mitral valve stenosis (MS) remains a prevalent finding. Percutaneous transvenous mitral commissurotomy (PTMC) is the intervention of choice for severe mitral stenosis (MS). We aimed to assess the mid-term outcome of PTMC in patients with immediate success.

2022年11月15日 · Introduction: Rheumatic heart disease (RHD), is a common cause of mitral stenosis (MS) in developing nations. As per current recommendation, Percutaneous Transvenous Mitral Commissurotomy (PTMC) is advised as a Class IA (I-Class Of Recommendation, COR; A-Level Of Evidence, LOE) indication in patients with symptomatic severe mitral stenosis.

2018年6月1日 · We report a case of successful PTMC in severe MS following MV repair for severe rheumatic MR. 1. Case report. A 34-year-old male, who underwent Aortic Valve replacement with mitral valve repair for rheumatic heart disease (RHD), Severe AR with moderate MR in 2007. Patient had NYHA class III Symptoms along with palpitation for 10–12 years.

2021年7月23日 · Rheumatic mitral stenosis remains the most common acquired heart disease needing intervention in developing countries. Percutaneous transcatheter mitral commissurotomy (PTMC) by the Inoue method has emerged as the most practical, safe, and effective means of relieving mitral stenosis in patients with favorable characteristics.

2014年9月30日 · Conclusion: Our study have shown that there is no association between hs-CRP and MV restenosis in patients with rheumatic heart disease (RHD) who underwent PTMC. Therefore, it has been postulated that inflammation is not a cause of post PTMC restenosis. Keywords: C-Reactive Protein (CRP), Inflammation, PTMC.

2022年6月12日 · The treatment strategies for clinically significant rheumatic MS are percutaneous mitral commissurotomy (PTMC) and mitral valve replacement (MVR). PTMC is the treatment of choice in patients with favorable clinical and valvular anatomical characteristics while some patients with contraindication to PTMC should undergo MVR. 4,5

2018年9月18日 · Individuals with severe mitral stenosis and suitable valve morphology benefit most from catheter-based interventions, especially percutaneous transvenous mitral commissurotomy (PTMC). Although there have been hardware improvements over the past 3 decades, the basic procedure is relatively unchanged.

2021年7月28日 · Among delayed RHD presentations, rheumatic mitral valve stenosis (MS) remains a prevalent finding. Percutaneous transvenous mitral commissurotomy (PTMC) is the intervention of choice for severe mitral stenosis (MS). We aimed to assess the mid-term outcome of PTMC in patients with immediate success.

2017年11月29日 · MV repair in RHD patients, using current techniques, can effectively correct hemodynamic and functional abnormalities with satisfactory results. 1 In a study by Choudhary et al. 2 718 patients with rheumatic severe MR underwent MV repair and three patients (0.4%) developed significant MS and all underwent reoperation.